The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.

Condition:   Charcot Marie Tooth Disease, Type 1 Intervention:   Drug: CLZ-2002 Sponsor:   Cellatoz Therapeutics, Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials